{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-002153","form_type":"8-K","ticker":null,"cik":"0001825413","company_name":"Biotech Acquisition Co","filed_at":"2023-01-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.841805+00:00","generated_at":"2026-06-20T16:38:40.242608+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Biotech Acquisition receives Nasdaq deficiency notice for missed annual meeting","bullets":["Received Nasdaq notice on Jan 9, 2023 for failing to hold annual meeting for FY ended Dec 31, 2021.","Company must submit a plan to regain compliance by Feb 23, 2023.","If plan accepted, Nasdaq may grant extension until June 29, 2023 to comply.","Deficiency notice has no immediate effect on listing or trading.","Company intends to submit a compliance plan within required timeframe."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-002153","json":"https://secwatch.observer/filing/0001213900-23-002153.json","markdown":"https://secwatch.observer/filing/0001213900-23-002153.md","text":"https://secwatch.observer/filing/0001213900-23-002153.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1825413/000121390023002153/0001213900-23-002153-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1825413/000121390023002153/ea171538-8k_biotechacq.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T16:38:40.242608+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"736fee4c48aad6069f9211a8d17b1addbd5cc311","claim":"Biotech Acquisition Co received a nasdaq deficiency notice notice regarding shareholders (rules 5620(a)).","evidence_excerpt":"January 9, 2023, Biotech Acquisition Company (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5620(a), due to the Company’s failure to hold an annual meeting of shareholders for the fiscal year ended December 31, 2021. The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on the Nasdaq Capital Market. The Notice states that the Com","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1825413/000121390023002153/0001213900-23-002153-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"shareholders"},{"label":"Rules","value":"5620(a)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}